Phase II study of allogeneic transplantation using transplant-lite conditioning regimes

Phase 2

Active, not recruiting

• Conditions: Metastatic renal cancer; Haematological malignancy; Cancer - Haematological diseases

• Registration Number: ACTRN12605000536662
• Lead Sponsor: Dr James Morton

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Summary of Patient/Donor Eligibility Criteria:1. Diagnosis of haematological malignancy or metastatic renal cancer. 2. ECOG performance status 0-2. 3. Either a suitable HLA-identical sibling donor, fit for peripheral blood stem cell collection (cohort 1) or a suitable HLA-mismatched (single HLA mismatch) sibling donor, fit for peripheral blood stem cell collection, available HLA-identical (HLA-A,B,DRB1) unrelated donor or available HLA-mismatched (single HLA mismatch) unrelated donor (cohort 2).

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified